Predictors of decrease in ankle-brachial index among patients with diabetes mellitus

Diabetic Medicine

Volumn 29, Issue 9, 2012, Pages

  Hoe, J ^a   Koh, W P ^b   Jin, A ^c   Sum, C F ^d   Lim, S C ^d   Tavintharan, S ^d  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c National Registry of Diseases Office   (Singapore)

^d KHOO TECK PUAT HOSPITAL   (Singapore)

Author keywords

Ankle brachial index; Diabetes; Peripheral artery disease; Progression

Indexed keywords

CREATININE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTICLE; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREDICTIVE VALUE; RETINOPATHY; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; AGED, 80 AND OVER; ANKLE BRACHIAL INDEX; BLOOD PRESSURE; CHOLESTEROL, LDL; CREATININE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; RISK FACTORS;

EID: 84865140694     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2012.03705.x     Document Type: Article

References (21)

1. O'Hare AM, Katz R, Shlipak MG, Cushman M, Newman AB. Mortality and cardiovascular risk across the ankle-arm index spectrum: results from the Cardiovascular Health Study. Circulation 2006; 113: 388-393.
2. Jude EB, Eleftheriadou I, Tentolouris N. Peripheral arterial disease in diabetes-a review. Diabet Med 2010; 27: 4-14.
3. Lekshmi Narayanan RM, Koh WP, Phang J, Subramaniam T. Peripheral arterial disease in community-based patients with diabetes in Singapore: results from a Primary Healthcare Study. Ann Acad Med Singapore 2010; 39: 525-527.
4. McDermott MM, Fried L, Simonsick E, Ling S, Guralnik JM. Asymptomatic peripheral arterial disease is independently associated with impaired lower extremity functioning: the women's health and aging study. Circulation 2000; 101: 1007-1012.
5. McDermott MM, Greenland P, Liu K, Guralnik JM, Criqui MH, Dolan NC et al. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. J Am Med Assoc 2001; 286: 1599-1606.
6. American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care 2003; 26: 3333-3341.
7. Criqui MH. Systemic atherosclerosis risk and the mandate for intervention in atherosclerotic peripheral arterial disease. Am J Cardiol 2001; 88: 43J-47J.
8. Ministry of Health. Diabetes Mellitus: Clinical Practice Guidelines 3/2006. Singapore: Ministry of Health, 2006.
9. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG et al. Inter-society consensus for the management of peripheral arterial disease (TASCII). Eur J Vasc Endovasc Surg 2007; 33: S1-S75.
10. Aboyans V, Criqui MH, Denenberg JO, Knoke JD, Ridker PM, Fronek A. Risk factors for progression of peripheral arterial disease in large and small vessels. Circulation 2006; 113: 2623-2629.
11. Kennedy M, Solomon C, Manolio TA, Criqui MH, Newman AB, Polak JF et al. Risk factors for declining ankle-brachial index in men and women 65years or older: the Cardiovascular Health Study. Arch Intern Med 2005; 165: 1896-1902.
12. Smith FB, Lee AJ, Price JF, van Wijk MC, Fowkes FG. Changes in ankle brachial index in symptomatic and asymptomatic subjects in the general population. J Vasc Surg 2003; 38: 1323-1330.
13. Palumbo PJ, O'Fallon WM, Osmundson PJ, Zimmerman BR, Langworthy AL, Kazmier FJ. Progression of peripheral occlusive arterial disease in diabetes mellitus. What factors are predictive? Arch Intern Med 1991; 151: 717-721.
14. Hsieh MC, Tien KJ, Perng DS, Hsiao JY, Chang SJ, Liang HT et al. Diabetic nephropathy and risk factors for peripheral artery disease in Chinese with type2 diabetes mellitus. Metabolism 2009; 58: 504-509.
15. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 2001; 134: 629-636.
16. Rose G, Hamilton PS, Keen H, Reid DD, McCartney P, Jarrett RJ. Myocardial ischaemia, risk factors and death from coronary heart-disease. Lancet 1977; 1: 105-109.
17. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90056 participants in 14 randomised trials of statins. Lancet 2005; 366: 1267-1278.
18. Cheung N, Wong TY. Diabetic retinopathy and systemic vascular complications. Prog Retin Eye Res 2008; 27: 161-176.
19. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 2004; 141: 413-420.
20. Adler AI, Erqou S, Lima TA, Robinson AH. Association between glycated haemoglobin and the risk of lower extremity amputation in patients with diabetes mellitus-review and meta-analysis. Diabetologia 2010; 53: 840-849.
21. Willigendael EM, Teijink JA, Bartelink ML, Kuiken BW, Boiten J, Moll FL et al. Influence of smoking on incidence and prevalence of peripheral arterial disease. J Vasc Surg 2004; 40: 1158-1165.